Connection

Ryan Tedford to Angiotensin-Converting Enzyme Inhibitors

Back to Details
This is a "connection" page, showing publications Ryan Tedford has written about Angiotensin-Converting Enzyme Inhibitors.
Ryan Tedford
Connection Strength
0.209
Angiotensin-Converting Enzyme Inhibitors
  1. Angiotensin II antagonism is associated with reduced risk for gastrointestinal bleeding caused by arteriovenous malformations in patients with left ventricular assist devices. J Heart Lung Transplant. 2017 Apr; 36(4):380-385.
    View in: PubMed
    Score: 0.124
  2. Angiotensin-converting enzyme inhibitor therapy after heart transplant: From molecular basis to clinical effects. Clin Transplant. 2022 07; 36(7):e14696.
    View in: PubMed
    Score: 0.045
  3. Endomyocardial Biopsy Characterization of Heart?Failure With Preserved Ejection?Fraction and Prevalence of Cardiac Amyloidosis. JACC Heart Fail. 2020 09; 8(9):712-724.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.